Knockdown of PFTK1 Inhibits the Migration of Glioma Cells
Authors:
- 4 August 2015
- journal article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 57 (2) , 257-264
Abstract
The prognosis of glioma patients is generally poor, so it is urgent to find out the underlying molecular mechanisms. PFTK1 is a member of cyclin-dependent kinases (Cdks) family and has been reported to contribute to tumor migration and invasion. In this study, we aimed to explore the expression and function in human glioma. Western blot and immunohistochemistry were used to evaluate the expression of PFTK1. PFTK1 expression was higher in glioma tissues compared with normal brain tissues, and its level was associated with the WHO grade in Western blot analysis. The suppression of PFTK1 expression by RNA interference was shown to inhibit the migration of glioma cells. Knockdown of PFTK1 increases E-cadherin expression and decreases vimentin expression. These data show that PFTK1 may participate in the pathogenic process of glioma, suggesting that PFTK1 can become a potential therapeutic strategy for gastric cancer.Keywords
This publication has 29 references indexed in Scilit:
- A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?British Journal of Radiology, 2012
- Enhancing Diagnosis, Prognosis, and Therapeutic Outcome Prediction of Gliomas Using GenomicsOMICS: A Journal of Integrative Biology, 2012
- Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinomaBritish Journal of Cancer, 2012
- Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2Cell, 2011
- Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersThe Lancet Neurology, 2010
- Cyclin-dependent kinases: a family portraitNature Cell Biology, 2009
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Epidemiology and etiology of gliomasActa Neuropathologica, 2005
- p29, a Novel GCIP-Interacting Protein, Localizes in the NucleusBiochemical and Biophysical Research Communications, 2000
- Cancer Cell CyclesScience, 1996